These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34994855)

  • 1. [Cytology of body cavity fluids - established methods and new developments].
    Engels M
    Pathologe; 2022 Mar; 43(2):91-98. PubMed ID: 34994855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of cytological material, pre-analytical procedures and bio-banking in effusion cytopathology.
    Engels M; Michael C; Dobra K; Hjerpe A; Fassina A; Firat P
    Cytopathology; 2019 Jan; 30(1):31-38. PubMed ID: 30430668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative analysis of conventional cytopreparatory and liquid based cytological techniques (Sure Path) in evaluation of serous effusion fluids.
    Dadhich H; Toi PC; Siddaraju N; Sevvanthi K
    Diagn Cytopathol; 2016 Nov; 44(11):874-879. PubMed ID: 27546351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytohistological correlation in serous effusions using the newly proposed International System for Reporting Serous Fluid Cytopathology: Experience of an oncological center.
    Lobo C; Costa J; Petronilho S; Monteiro P; Leça L; Schmitt F
    Diagn Cytopathol; 2021 May; 49(5):596-605. PubMed ID: 32339444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytological variations observed in the malignant cells in body cavity fluids].
    Matsuda M
    Rinsho Byori; 1990 Nov; Suppl 87():69-85. PubMed ID: 2287091
    [No Abstract]   [Full Text] [Related]  

  • 6. Reassessing the optimal volume for malignancy detection in serous fluid cytology.
    Coconubo DM; Baskota SU; Li R; Srivastava P; Cuda J; Khader S
    Cancer Cytopathol; 2022 Jul; 130(7):551-557. PubMed ID: 35468659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, cytologic, and immunohistochemical features of sarcomas involving body cavity fluids.
    Chen AL; Janko E; Pitman MB; Chebib I
    Cancer Cytopathol; 2019 Dec; 127(12):778-784. PubMed ID: 31693303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of diagnostic value of cytological smear method versus cell block method in body fluid cytology: study of 150 cases.
    Bhanvadia VM; Santwani PM; Vachhani JH
    Ethiop J Health Sci; 2014 Apr; 24(2):125-31. PubMed ID: 24795513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of the newly published International System for Reporting Serous Fluid Cytopathology in atypical and suspicious diagnosis: a four-year retrospective analysis.
    Shen Y; Gosnell JM; Nawgiri R; Muthukumarana V
    J Am Soc Cytopathol; 2024; 13(4):303-308. PubMed ID: 38637263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive effusion cytology as the initial presentation of malignancy.
    Monte SA; Ehya H; Lang WR
    Acta Cytol; 1987; 31(4):448-52. PubMed ID: 3604540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the impact of the International System for Serous Fluid Cytopathology.
    Mikou P; Pergaris A; Engels M; Chandra A
    Cytopathology; 2024 Jan; 35(1):16-22. PubMed ID: 37795809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serous effusions in malignant lymphomas: a review.
    Das DK
    Diagn Cytopathol; 2006 May; 34(5):335-47. PubMed ID: 16604559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of International System for Reporting Serous Fluid Cytopathology: A systematic review and meta-analysis in malignancy diagnosis.
    Ahuja S; Ahuja R; Pandey S; Zaheer S
    Cancer Cytopathol; 2024 Oct; 132(10):609-620. PubMed ID: 38613789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ancillary studies in pleural, pericardial, and peritoneal effusion cytology.
    Sundling KE; Cibas ES
    Cancer Cytopathol; 2018 Aug; 126 Suppl 8():590-598. PubMed ID: 30156768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Special stains, the old and the new: the impact of immunocytochemistry in effusion cytology.
    Bedrossian CW
    Diagn Cytopathol; 1998 Feb; 18(2):141-9. PubMed ID: 9484644
    [No Abstract]   [Full Text] [Related]  

  • 16. Application of the International System for Reporting Serous Fluid Cytopathology (TIS): A retrospective institutional study.
    Straccia P; Chiappetta M; Magnini D; Cancellieri A
    Cytopathology; 2022 May; 33(3):305-311. PubMed ID: 35213747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytomorphology, clinicopathologic, and cytogenetics correlation of myelomatous effusion of serous cavities: A retrospective review.
    Harbhajanka A; Brickman A; Park JW; Reddy VB; Bitterman P; Gattuso P
    Diagn Cytopathol; 2016 Sep; 44(9):742-7. PubMed ID: 27434129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subclassification of lymphoproliferative disorders in serous effusions: a 10-year experience.
    Tong LC; Ko HM; Saieg MA; Boerner S; Geddie WR; da Cunha Santos G
    Cancer Cytopathol; 2013 May; 121(5):261-70. PubMed ID: 23460311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The international system for reporting serous fluid cytopathology-diagnostic categories and clinical management.
    Pinto D; Chandra A; Crothers BA; Kurtycz DFI; Schmitt F
    J Am Soc Cytopathol; 2020; 9(6):469-477. PubMed ID: 32620534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomorphology, Immunophenotype, and cytogenetic profile of leukemic serous effusions.
    Kaur K; Patel T; Patra S; Trivedi P
    Diagn Cytopathol; 2021 Aug; 49(8):948-958. PubMed ID: 33973738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.